Phenobarbital for Treatment of Alcohol Withdrawal

REFERENCES

• Bailly D., Servant D., Blandin N., Beuscart R., Parquet P. J. Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam. Biomedicine and Pharmacotherapy. 1992; 46: 419–424
   PubMed Web of Science ®Google Scholar
• Becker H. C., Veatch L. M. Effects of lorazepam treatment for multiple ethanol withdrawals in mice. Alcoholism-Clinical and Experimental Research 2002; 26: 371–380
   PubMedGoogle Scholar
• Cross G. M., Hennessey P. T. Principles and practice of detoxification. Primary Care 1993; 20: 81–93
   PubMedGoogle Scholar
• DeCarolis D. D., Rice K. L., Ho L., Willenbring M. L., Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007; 27: 510–518
   PubMedGoogle Scholar
• Flygenring J., Hansen J., Holst J., Petersen E., Sorensen A. Treatment of alcohol withdrawal symptoms in hospitalized patients. Acta Psychiatra Scandinavica. 1984; 69: 398–408
   PubMed Web of Science ®Google Scholar
• Gold J. A., Rimal B., Nolan A., Nelson L. S. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Critical Care Medicine. 2007; 35: 724–730
   PubMed Web of Science ®Google Scholar
• Grobin A. C., Matthews D. B., Devaud L. L., Morrow A. L. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology. 1998; 139: 2–19
   PubMed Web of Science ®Google Scholar
• Hadama A., Ieiri I., Morita T., Kimura M., Urae A., Irie S., Kanneda T., Mamiya K., Tashiro N., Hiquchi S., Otsubo K. P-hydroxylation of phenobarbital: Relationship to (S) mephenytoin hydroxylation (CYP2C19) polymorphism. Therapeutic Drug Monitoring. 2001; 23: 115–118
   PubMed Web of Science ®Google Scholar
• Ives T. J., Mooney A. J., Gwyther R. E. Pharmacokinetic dosing of phenobarbital in the treatment of alcohol withdrawal syndrome. Southern Medical Journal. 1991; 84: 18–21
   PubMed Web of Science ®Google Scholar
• Kramp P., Rafaelsen O. J. Delirium tremens: A double-blind comparison of diazepam and barbital treatment. Acta Psychiatra Scandanavica. 1978; 58: 174–190
   PubMedGoogle Scholar
• Krystal J. H., Petrakis I. L., Krupitsky E., Schutz C., Trevisan L., D'Souza D. C. NMDA receptor antagonism and the ethanol intoxication signal. Annals of the New York Academy of Sciences 2003; 1003: 176–184
   PubMed Web of Science ®Google Scholar
• Lago J. A., Lago C. P., Lago A. A., II. Alcohol withdrawal in the hospitalized patient. Resident & Staff Physician 1994; 40: 27–30
   Google Scholar
• Mariani J. J., Rosenthal R. N., Tross S., Singh P., Anand O. P. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. American Journal on Addictions. 2006; 15: 76–84
   PubMed Web of Science ®Google Scholar
• Martin P. R., Bhushan C. M., Kapur B. M., Whiteside E. A., Sellers E. M. Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions. Clinical Pharmacology and Therapeutics. 1979; 26: 256–264
   PubMed Web of Science ®Google Scholar
• Matz R. Barbiturates and alcohol withdrawal. Journal of General Internal Medicine 1990; 5: 182, [Letter]
   PubMedGoogle Scholar
• Mayo-Smith M. F. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline. Journal of the American Medical Association. 1997; 278: 144–151
   PubMed Web of Science ®Google Scholar
• McMicken D. B., Freedland E. S. Alcohol-related seizures: Pathophysiology, differential diagnosis, evaluation, and treatment. Emergency Medicine Clinics of North America. 1994; 12: 1057–1079
   PubMedGoogle Scholar
• Olkkola K. T., Ahonen J. Midazolam and other benzodiazepines. Handbook of Experimental Pharmacology. 2008; 182: 335–360
   PubMedGoogle Scholar
• Robinson G. M., Sellers E. M., Janacek E. Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique. Clinical Pharmacology & Therapeutics. 1981; 30: 71–76
   PubMed Web of Science ®Google Scholar
• Saitz R. Recognition and management of occult alcohol withdrawal. Hospital Practice 1995; 49–58, June 15
   Google Scholar
• Saitz R., Mayo-Smith M. F., Roberts M. S., Redmond H. A., Bernard D. R., Calkins D. R. Individualized treatment for alcohol withdrawal: A randomized double-blind controlled trial. Journal of the American Medical Association 1994; 272: 519–523
   PubMed Web of Science ®Google Scholar
• Schnoll S. H. Drug abuse, overdose, and withdrawal syndromes. Textbook of critical care, 3rd ed., S. M. Ayres, A. Grenvik, P. R. Holbrook, W. C. Shoemaker. WB Saunders Co, Philadelphia 1995; 1176–1186
   Google Scholar
• Smith D. E., Wesson D. R. Phenobarbital technique for treatment of barbiturate dependence. Archives of General Psychiatry. 1971; 24: 56–60
   PubMed Web of Science ®Google Scholar
• Tsai G., Coyle J. T. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annual Revue of Medicine 1998; 49: 173–184
   PubMed Web of Science ®Google Scholar
• Wartenberg A. A., Nirenberg T. D., Liepman M. R., Silvia L. Y., Begin A. M., Monti P. M. Detoxification of alcoholics: Improving care by symptom-triggered sedation. Alcoholism-Clinical and Experimental Research. 1990; 14: 71–75
   PubMed Web of Science ®Google Scholar
• Weaver M. F., Hoffman H. J., Johnson R., Mauck K. L. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. Journal of Addictive Diseases. 2006; 25: 17–24
   PubMed Web of Science ®Google Scholar
• Weaver M. F., Jarvis M. A.E., Schnoll S. H. Role of the primary care physician in problems of substance abuse. Archives of Internal Medicine 1999; 159: 913–924
   PubMed Web of Science ®Google Scholar
• Weaver M. F., Schnoll S. H. Drug overdose and withdrawal syndromes. Current Opinion in Critical Care 1996; 2: 242–247
   Google Scholar
• Wiehl W. O., Hayner G., Galloway G. Haight Ashbury Free Clinics' drug detoxification protocols. Part 4: Alcohol. Journal of Psychoactive Drugs 1994; 26: 57–59
   PubMed Web of Science ®Google Scholar
• Yeh H., Dopesh V., Maany I. Seizures during detoxification. Journal of General Internal Medicine 1992; 7: 123, [Letter]
   PubMedGoogle Scholar
• Young G. P., Rores C., Murphy C., Dailey R. H. Intravenous phenobarbital for alcohol withdrawal and convulsions. Annals of Emergency Medicine 1987; 16: 847–850
   PubMedGoogle Scholar
• Zacharias S., Rodriguez-Garcia A., Honz N., Hooper C. Development of an alcohol withdrawal clinical pathway: an interdisciplinary process. Journal of Nursing Care Quality 1998; 12(3)9–18
   PubMedGoogle Scholar